Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hemostasis
•
Hematology
•
Benign Hematology
•
Hemophilia
What is your recommended management algorithm for bleeding associated with an acquired factor VIII inhibitor?
Answer from: at Community Practice
Fragner et al., Cureus 2022.
Sign in or Register to read more
12811
Related Questions
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
How do you manage DIC associated with an aortic aneurysm while awaiting surgical repair?
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
In what situations would you consider ESAs in hospitalized patients with severe anemia for indications other than CKD or myelosuppressive chemotherapy (e.g., ACD, hemorrhage)?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen-containing vaginal ring for contraception?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?